These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 14758817)
1. Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway. Bodd TL; Reichelt J; Heimdal K; Moller P J Genet Couns; 2003 Oct; 12(5):405-17. PubMed ID: 14758817 [TBL] [Abstract][Full Text] [Related]
2. Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway. Levin T; Mæhle L Fam Cancer; 2017 Apr; 16(2):257-265. PubMed ID: 27804060 [TBL] [Abstract][Full Text] [Related]
3. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Finlay E; Stopfer JE; Burlingame E; Evans KG; Nathanson KL; Weber BL; Armstrong K; Rebbeck TR; Domchek SM Genet Test; 2008 Mar; 12(1):81-91. PubMed ID: 18373407 [TBL] [Abstract][Full Text] [Related]
4. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868 [TBL] [Abstract][Full Text] [Related]
5. [Information to families with hereditary breast and ovarian cancer]. Levin T; Reichelt J; Heimdal K; Møller P Tidsskr Nor Laegeforen; 2001 Nov; 121(28):3292-4. PubMed ID: 11826460 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
7. Uptake of genetic counseling among adult children of BRCA1/2 mutation carriers in France. Gauna Cristaldo FB; Touzani R; Apostolidis T; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Fricker JP; Berthet P; Julian-Reynier C; Mancini J; Noguès C; Bouhnik AD Psychooncology; 2019 Sep; 28(9):1894-1900. PubMed ID: 31276266 [TBL] [Abstract][Full Text] [Related]
8. Costs and benefits of diagnosing familial breast cancer. Heimdal K; Maehle L; Møller P Dis Markers; 1999 Oct; 15(1-3):167-73. PubMed ID: 10595273 [TBL] [Abstract][Full Text] [Related]
9. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests. Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829 [TBL] [Abstract][Full Text] [Related]
10. Testing participation in BRCA1/2-positive families: initiator role of index cases. Blandy C; Chabal F; Stoppa-Lyonnet D; Julian-Reynier C Genet Test; 2003; 7(3):225-33. PubMed ID: 14658447 [TBL] [Abstract][Full Text] [Related]
11. Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers. Fehniger J; Lin F; Beattie MS; Joseph G; Kaplan C J Genet Couns; 2013 Oct; 22(5):603-12. PubMed ID: 23666114 [TBL] [Abstract][Full Text] [Related]
12. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240 [TBL] [Abstract][Full Text] [Related]
13. Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach. Samimi G; Bernardini MQ; Brody LC; Caga-Anan CF; Campbell IG; Chenevix-Trench G; Couch FJ; Dean M; de Hullu JA; Domchek SM; Drapkin R; Spencer Feigelson H; Friedlander M; Gaudet MM; Harmsen MG; Hurley K; James PA; Kwon JS; Lacbawan F; Lheureux S; Mai PL; Mechanic LE; Minasian LM; Myers ER; Robson ME; Ramus SJ; Rezende LF; Shaw PA; Slavin TP; Swisher EM; Takenaka M; Bowtell DD; Sherman ME J Clin Oncol; 2017 Jul; 35(20):2329-2337. PubMed ID: 28398847 [TBL] [Abstract][Full Text] [Related]
14. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Landsbergen K; Verhaak C; Kraaimaat F; Hoogerbrugge N Fam Cancer; 2005; 4(2):115-9. PubMed ID: 15951961 [TBL] [Abstract][Full Text] [Related]
15. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer. Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131 [TBL] [Abstract][Full Text] [Related]
16. Fertility intentions following testing for a BRCA1 gene mutation. Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303 [TBL] [Abstract][Full Text] [Related]
17. BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations. Borg A; Dørum A; Heimdal K; Maehle L; Hovig E; Møller P Dis Markers; 1999 Oct; 15(1-3):79-84. PubMed ID: 10595257 [TBL] [Abstract][Full Text] [Related]
18. BRCA1/2 predictive testing and gender: uptake, motivation and psychological characteristics. Denayer L; Boogaerts A; Philippe K; Legius E; Evers-Kiebooms G Genet Couns; 2009; 20(4):293-305. PubMed ID: 20162864 [TBL] [Abstract][Full Text] [Related]
19. [Information spreading about hereditary carriage of a BRCA1/2 mutation and ovarian cancer and rate of consultation of the concerned relatives]. Christophe V; Leroy T; Adenis C; Reich M; Vennin P Bull Cancer; 2008 Apr; 95(4):395-402. PubMed ID: 18495568 [TBL] [Abstract][Full Text] [Related]